Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan

NCT00625469 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped competing studies did not allow enrollment

Conditions

Pulmonary Arterial Hypertension
Idiopathic Pulmonary Fibrosis

Interventions

DRUG: bosentan

Sponsor

Rajan Saggar

Collaborators

[object Object]